结核病与肺部健康杂志 ›› 2013, Vol. 2 ›› Issue (4): 289-291.doi: 10.3969/j.issn.2095-3755.2013.04.015

• 论著 • 上一篇    下一篇

家庭支持对耐多药肺结核患者治疗依从性和治愈率的影响

苏静怡,杜雨华,张凤玲,林茵,杜彩云,欧阳彩虹,曹满霞,黎意芬   

  1. 510095 广州市胸科医院第二分所诊疗科
  • 收稿日期:2013-10-20 出版日期:2013-11-30 发布日期:2013-11-30
  • 通信作者: 苏静怡,Email:siyhgf@163.com

Influence of family support on treatment compliance and cure rate of MDR-TB patients

SU Jing-yi,DU Yu-hua, ZHANG Feng-ling, LIN Yin, DU Cai-yun, OUYANG Cai-hong,CAO Man-xia, LI Yi-fen   

  1. The Diagnosis and Treatment Office of Second Clinic of Guangzhou Chest-Disease Hospital, Guangzhou 510095,China
  • Received:2013-10-20 Online:2013-11-30 Published:2013-11-30
  • Contact: SU Jing-yi, Email: sjyhgf@163.com

摘要: 目的 探讨耐多药肺结核患者家庭支持对患者治疗依从性和治愈率的影响。方法 采用自行设计的调查问卷,对广州市胸科医院结核二门诊2010年1月至2013年6月收治的治疗满疗程的44例耐多药肺结核患者的家庭支持度与患者治疗依从性和治愈率的关系进行分析。共发放问卷44份,回收有效问卷44份,有效回收率100.0%。同时对家庭高支持度和低支持度患者治疗的依从性和治愈率采用卡方检验,以P<0.05为差异有统计学意义。结果 按照问卷调查的结果,家庭高度支持的患者中治疗依从性好的占90.9%(30/33),治愈率为81.8%(27/33);家庭低度支持的患者中治疗依从性好的占54.5%(6/11),治愈率为45.5%(5/11)。家庭高度支持较家庭低度支持的患者在治疗依从性和临床治愈率方面差异均有统计学意义(校正χ2值分别为5.09、3.82,P值均<0.05)。结论 家庭支持度直接影响耐多药肺结核患者的治疗依从性和治愈率。因此,应重视对患者家属成员的教育,保证高质量的家庭支持,提高耐多药肺结核患者的治疗依从性和治愈率。

Abstract: Objective To study the influence of family support on treatment compliance and cure rate of MDR-TB patients. Methods A total of 44 MDR-TB patients were registered who finished the full course treatment in the Guangzhou Chest-Disease Hospital from Jan. 2010 to Jun. 2013. The patients were interviewed by the self-designed questionnaires and the relationship between family support,treatment compliance and cure rate were analyzed. All questionnaires were returned. At same time, we analyzed treatment compliance and cure rate between different family support by Chi-square statistics test, P<0.05 was considered statistically significant. Results The family support can improve the MDR-TB patients’ treatment compliance and cure rate. patients with good family support had good treatment compliance(90.9%,30/33) and cure rate (81.8%,27/33). But the treatment comp-liance and cure rate were 54.5%(6/11) and 45.5% (5/11)respectively in patients with low family support. The two groups were significantly different in treatment compliance and cure rate (corrected χ2=5.09, 3.82, P<0.05). Conclusion The family support is very important to the treatment results of MDR-TB patients. We should pay attention to the health education for MDR-TB cases’ family members and ensure the patients to get the high quality family support.